Kannangai, R., Vivekanandan, P., Martinez-Murillo, F., Choti, M. and Torbenson, M. (2007) Fibrolamellar Carcinomas Show Over-Expression of Genes in the RAS, MAPK, PIK3, and Xenobiotic Degradation Pathways. Human Pathology, 38, 639-644.
http://dx.doi.org/10.1016/j.humpath.2006.07.019

has been cited by the following article:

• TITLE: Fibrolamellar Carcinoma: A Distinct Variant of Hepatocellular Carcinoma That Is Still Surrounded by Unveils Mysteries

  AUTHORS: Consolato Sergi

  KEYWORDS: Liver, Tumor, Carcinoma, Pathogenesis, Differential Diagnosis, Therapy, Prognosis

  JOURNAL NAME: Journal of Cancer Therapy, Vol.5 No.14, December 3, 2014

  ABSTRACT: Fibrolamellar carcinoma (FL-HCC) is overall a quite rare variant of hepatocellular carcinoma (HCC)that is intriguing and poorly understood at same time. In humans, it affects essentially the young population (children and young adults) in the peculiar absence of underlying liver diseases. FL-HCC has distinctiveclinico-pathologic features with metastases frequently found in the regional lymph nodes, but also peritoneum and lungs. Although initially considered harboring an indolent course, survival outcomes have been recently updated pointing to a neoplasm concealing many aspects of biogenesis. In this review, morphology, molecular pathways, and prognosis of this rare tumor are presented.